Science
Moderna's mRNA cancer vaccine shows promise
Moderna and Merck’s latest mRNA cancer vaccine has demonstrated effectiveness in preventing recurrence and reducing mortality. The results are a significant step forward in cancer immunotherapy research.
Coverage timeline — 1 article
Scientific American
The Moderna-Merck mRNA cancer vaccine helps prevent cancer recurrence and death, the new results show
2026-10-22 22:55 UTC